[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338067-105":59,"doc-detail-338067-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","integrated-bioinformatics-analysis-of-nucleotide-metabolism-based-molecular-subtyping-and-biomarkers-in-lung-adenocarcinoma","Integrated Bioinformatics Analysis of Nucleotide Metabolism Based Molecular Subtyping and Biomarkers in Lung Adenocarcinoma","","Lung adenocarcinoma (LUAD) remains difficult to treat due to tumor heterogeneity and a complex tumor microenvironment. This study evaluates how dysregulated nucleotide metabolism relates to molecular subtyping, clinical features, prognosis, and immune interactions. Using TCGA data with NMF clustering, WGCNA, and machine-learning approaches, then validating key genes experimentally, the work identifies two LUAD subtypes with distinct outcomes and an NMRS based on 28 genes.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrated-bioinformatics-analysis-of-nucleotide-metabolism-based-molecular-subtyping-and-biomarkers-in-lung-adenocarcinoma/338067/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrated-bioinformatics-analysis-of-nucleotide-metabolism-based-molecular-subtyping-and-biomarkers-in-lung-adenocarcinoma/338067.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical problem does the study target in lung adenocarcinoma?","Question",{"text":112,"@type":113},"It addresses the difficulty of improving outcomes in LUAD caused by tumor heterogeneity and the complexity of the tumor microenvironment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were LUAD molecular subtypes and associations identified?",{"text":117,"@type":113},"LUAD samples from TCGA were analyzed using NMF clustering, WGCNA, and machine-learning methods, followed by analyses of immune microenvironment relationships including single-cell data.",{"name":119,"@type":110,"acceptedAnswer":120},"What is NMRS and how does it relate to prognosis?",{"text":121,"@type":113},"NMRS is a nucleotide metabolism-related score calculated from the expression of 28 key genes, which differentiates patient outcomes and predicts links to oncogenic pathways and immune responses.",{"name":123,"@type":110,"acceptedAnswer":124},"Which nucleotide metabolism gene is highlighted as an oncogenic factor?",{"text":125,"@type":113},"AUNIP is reported as an oncogene that promotes LUAD cell proliferation and is associated with tumor immune infiltration.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},338067,1790701947,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":36,"preview_page_count":19,"preview_urls":149},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","TYPE Original Research PUBLISHED 01 August 2024  \nDOI 10.3389/fimmu.2024.1430171  \nOPEN ACCESS  \nEDITED BY Binfeng Lu,  \nHackensack Meridian Health, United States  \nREVIEWED BY Fanhua Kong,  \nWuhan University, China Dafei Chai,  \nXuzhou Medical University, China  \n*CORRESPONDENCE Haiqin Wang  \n [wanghaiqin77@csu.edu.cn](wanghaiqin77@csu.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 09 May 2024  \nACCEPTED 17 July 2024  \nPUBLISHED 01 August 2024  \nCITATION  \nLuo D, Wang H, Zeng Z, Chen J and Wang H (2024) Integrated bioinformatics analysis of nucleotide metabolism based molecular subtyping and biomarkers in lung adenocarcinoma.  \nFront. Immunol. 15:1430171 .  \ndoi: 10.3389/fimmu.2024.1430171  \nCOPYRIGHT  \n© 2024 Luo, Wang, Zeng, Chen and Wang.  \nThis is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nIntegrated bioinformatics analysis of nucleotide metabolism based molecular subtyping and biomarkers in lung adenocarcinoma  \nDayuan Luo 1,2†, Haohui Wang 1,2†, Zhen Zeng 3,4, Jiajing Chen 3,4 and Haiqin Wang 3,4*  \n1 Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China, 2 Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China,  \n3 Department of Geriatrics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China, 4 Hunan Clinical Medical Research Center for Geriatric Syndrome, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China  \nBackground: Lung adenocarcinoma (LUAD), a predominant subtype of nonsmall cell lung cancers, continues to challenge treatment outcomes due to its heterogeneity and complex tumor microenvironment (TME) . Dysregulation in nucleotide metabolism has been identiﬁed as a sign iﬁcant factor in tumorigenesis, suggesting its potential as a therapeutic target.  \nMethods: This study analyzed LUAD samples from The Cancer Genome Atlas (TCGA) using Non-negative Matrix Factorization (NMF) clustering, Weighted Correlation Network Analysis (WGCNA), and various machine learning techniques. We investigated the role of nucleotide metabolism in relation to clinical features and immune microenvironment through large-scale data analysis and single-cell sequencing. Using in vivo and in vitro experiments such as RT-qPCR, Western Blot, immunohistochemistry, and subcutaneous tumor formation in mice, we further validated the functions of key nucleotide metabolism genes in cell lines and animals.  \nResults: Nucleotide metabolism genes classiﬁed LUAD patients into two distinct subtypes with signiﬁcant prognostic differences. The ‘C1’subtype associated with active nucleotide metabolism pathways showed poorer prognosis and a more aggressive tumor phenotype. Furthermore, a nucleotide metabolism-related score (NMRS) calculated from the expression of 28 key genes effectively differentiated between patient outcomes and predicted associations with oncogenic pathways and immune responses. By integrating various immune inﬁltration algorithms, we delineated the associations between nucleotide metabolism signature genes and the tumor microenvironment, and characterized their distribution differences at the cellular level by analyzing single-cell sequencing dataset related to immunochemotherapy. Finally, we demonstrated the differential expression of the key nucleotide metabolism gene AUNIP acts as an oncogene to promote LUAD cell proliferation and is associated with tumor immune inﬁltration.  \nFrontiers in Immunology 01 [","cbCaisJoUjgKM8kt","https://ap.wps.com/l/cbCaisJoUjgKM8kt","pdf",19942232,16,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What clinical problem does the study target in lung adenocarcinoma?\",\"answer\":\"It addresses the difficulty of improving outcomes in LUAD caused by tumor heterogeneity and the complexity of the tumor microenvironment.\"},{\"question\":\"How were LUAD molecular subtypes and associations identified?\",\"answer\":\"LUAD samples from TCGA were analyzed using NMF clustering, WGCNA, and machine-learning methods, followed by analyses of immune microenvironment relationships including single-cell data.\"},{\"question\":\"What is NMRS and how does it relate to prognosis?\",\"answer\":\"NMRS is a nucleotide metabolism-related score calculated from the expression of 28 key genes, which differentiates patient outcomes and predicts links to oncogenic pathways and immune responses.\"},{\"question\":\"Which nucleotide metabolism gene is highlighted as an oncogenic factor?\",\"answer\":\"AUNIP is reported as an oncogene that promotes LUAD cell proliferation and is associated with tumor immune infiltration.\"}]","Integrated Bioinformatics Analysis of Nucleotide Metabolism Based Molecular Subtyping and Biomarkers in Lung Adenocarcinoma | PDF",1790021806,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dee353a9df89e2cdd544692186388b02.webp",983,1389,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b78076d1bb124f6e75ebcfc65abe44c.webp",982,1388,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/28988fd8cc67846040ee1e636dea50f1.webp",981,1386,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9572ee3252fd28cebaf56d138ed652f3.webp",980,1385]